BLACKBOXSTOCKS INC (BLBX) Fundamental Analysis & Valuation
NASDAQ:BLBX • US09229E3036
Current stock price
18.15 USD
+2.75 (+17.86%)
At close:
18.1 USD
-0.05 (-0.28%)
After Hours:
This BLBX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BLBX Profitability Analysis
1.1 Basic Checks
- In the past year BLBX has reported negative net income.
- BLBX had a negative operating cash flow in the past year.
- In the past 5 years BLBX always reported negative net income.
- BLBX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- BLBX has a Return On Assets of -42.72%. This is amonst the worse of the industry: BLBX underperforms 82.97% of its industry peers.
- With a Return On Equity value of -78.75%, BLBX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.72% | ||
| ROE | -78.75% | ||
| ROIC | N/A |
ROA(3y)-66.07%
ROA(5y)-50.38%
ROE(3y)-119.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BLBX has a Gross Margin of 39.39%. This is in the lower half of the industry: BLBX underperforms 77.17% of its industry peers.
- In the last couple of years the Gross Margin of BLBX has grown nicely.
- BLBX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.22%
GM growth 5Y4.74%
2. BLBX Health Analysis
2.1 Basic Checks
- BLBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- BLBX has more shares outstanding than it did 1 year ago.
- BLBX has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for BLBX is higher compared to a year ago.
2.2 Solvency
- BLBX has an Altman-Z score of 6.05. This indicates that BLBX is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of BLBX (6.05) is better than 80.80% of its industry peers.
- BLBX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.03, BLBX perfoms like the industry average, outperforming 59.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.05 |
ROIC/WACCN/A
WACC11.13%
2.3 Liquidity
- A Current Ratio of 0.04 indicates that BLBX may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.04, BLBX is doing worse than 97.83% of the companies in the same industry.
- BLBX has a Quick Ratio of 0.04. This is a bad value and indicates that BLBX is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.04, BLBX is doing worse than 97.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 |
3. BLBX Growth Analysis
3.1 Past
- The earnings per share for BLBX have decreased by -7.38% in the last year.
- The Revenue for BLBX has decreased by -13.58% in the past year. This is quite bad
- Measured over the past years, BLBX shows a quite strong growth in Revenue. The Revenue has been growing by 19.35% on average per year.
EPS 1Y (TTM)-7.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.19%
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y-25.1%
Revenue growth 5Y19.35%
Sales Q2Q%7.59%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. BLBX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BLBX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. BLBX Dividend Analysis
5.1 Amount
- No dividends for BLBX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BLBX Fundamentals: All Metrics, Ratios and Statistics
18.15
+2.75 (+17.86%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-16 2025-10-16
Earnings (Next)03-19 2026-03-19
Inst OwnersN/A
Inst Owner Change11.97%
Ins OwnersN/A
Ins Owner Change-0.17%
Market Cap78.23M
Revenue(TTM)2.39M
Net Income(TTM)-3.77M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 32.76 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 16.35 | ||
| P/tB | 16.35 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0.55
BVpS1.11
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.72% | ||
| ROE | -78.75% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.39% | ||
| FCFM | N/A |
ROA(3y)-66.07%
ROA(5y)-50.38%
ROE(3y)-119.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.22%
GM growth 5Y4.74%
F-Score2
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 | ||
| Altman-Z | 6.05 |
F-Score2
WACC11.13%
ROIC/WACCN/A
Cap/Depr(3y)118.66%
Cap/Depr(5y)131.2%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y-25.1%
Revenue growth 5Y19.35%
Sales Q2Q%7.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.15%
OCF growth 3YN/A
OCF growth 5YN/A
BLACKBOXSTOCKS INC / BLBX Fundamental Analysis FAQ
What is the fundamental rating for BLBX stock?
ChartMill assigns a fundamental rating of 1 / 10 to BLBX.
What is the valuation status for BLBX stock?
ChartMill assigns a valuation rating of 0 / 10 to BLACKBOXSTOCKS INC (BLBX). This can be considered as Overvalued.
How profitable is BLACKBOXSTOCKS INC (BLBX) stock?
BLACKBOXSTOCKS INC (BLBX) has a profitability rating of 1 / 10.